title: Surgical ablation of atrial fibrillation with bipolar radiofrequency as the primary modality.
abstract: OBJECTIVE
  In studying cardiac surgical patients undergoing atrial fibrillation ablation with bipolar radiofrequency, we sought to (1) quantify the time-related prevalence of atrial fibrillation postoperatively and identify its risk factors and (2) determine time-related ablation failure and its risk factors.
  
  
  METHODS
  From November 2001 to January 2004, 513 patients underwent atrial fibrillation ablation (bipolar radiofrequency alone or with cryothermy) and other cardiac operations. Rhythm documented on 3495 postoperative electrocardiograms was used to estimate the prevalence of and risk factors for atrial fibrillation across time. Ablation failure was defined as occurrence of atrial fibrillation any time beyond 6 months after operation.
  
  
  RESULTS
  Prevalence of postoperative atrial fibrillation peaked at about 1 month, decreased to 13% at 6 months, and gradually increased thereafter. Risk factors associated with increased prevalence varied by time period and included older age ( P = .004) for early occurrence, lesion set in permanent atrial fibrillation ( P = .02) for late occurrence, and larger left atrial diameter ( P = .02) and permanent atrial fibrillation ( P < .0001) for occurrence across the entire time span. Freedom from ablation failure was 72% at 12 months. Risk factors for ablation failure included lesion set in permanent atrial fibrillation ( P = .001), longer duration of atrial fibrillation ( P = .01), and larger left atrial diameter ( P = .03).
  
  
  CONCLUSIONS
  Bipolar radiofrequency enables extension of ablation to most cardiac surgical patients with atrial fibrillation. Recurrence is influenced by the type and duration of atrial fibrillation, choice of lesion set in permanent atrial fibrillation, and left atrial size. Early operation, careful choice of lesion set, and left atrial reduction might enhance results.
authors.affiliation: Center for Atrial Fibrillation and the Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio, USA. gillinom@ccf.org
authors.forename: A Marc
authors.initials: AM
authors.lastname: Gillinov
authors.forename: Patrick M
authors.initials: PM
authors.lastname: McCarthy
authors.forename: Eugene H
authors.initials: EH
authors.lastname: Blackstone
authors.forename: Jeevanantham
authors.initials: J
authors.lastname: Rajeswaran
authors.forename: Gosta
authors.initials: G
authors.lastname: Pettersson
authors.forename: Joseph F
authors.initials: JF
authors.lastname: Sabik
authors.forename: Lars G
authors.initials: LG
authors.lastname: Svensson
authors.forename: Delos M
authors.initials: DM
authors.lastname: Cosgrove
authors.forename: Kathleen M
authors.initials: KM
authors.lastname: Hill
authors.forename: Gonzalo V
authors.initials: GV
authors.lastname: Gonzalez-Stawinski
authors.forename: Nassir
authors.initials: N
authors.lastname: Marrouche
authors.forename: Andrea
authors.initials: A
authors.lastname: Natale
mesh_terms: D000368:Aged; D001281:Atrial Fibrillation / Q000453:epidemiology / Q000601:surgery*; D017115:Catheter Ablation; D005260:Female; D006801:Humans; D008297:Male; D015995:Prevalence; D012307:Risk Factors; D017211:Treatment Failure